Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy/Experiment 5/Signature 1

EditHistoryDelete

Mark reviewed

Your review change was submitted

Needs review

Curated date: 2024/11/09

Curator: KateRasheed

Revision editor(s): KateRasheed

Source: Additional file 4: Figure S4

Description: Differentially abundant bacterial taxa between the naive and TB + HRZ groups at 4months into anti-tuberculosis HR therapy(end of therapy).

Abundance in Group 1: increased abundance in TB +HRZ group - 4months HR(W20)

NCBI	Quality Control	Links
Barnesiella
Anaerorhabdus
Porphyromonas
Prolixibacter
Tannerella
Paraprevotella
Parasutterella
Akkermansia
Thomasclavelia
Olsenella
Bifidobacterium
Desulfovibrio
Paraeggerthella
Eggerthia
Odoribacter
Christensenella
Parvibacter
Adlercreutzia
Pseudobacteroides

Revision editor(s): KateRasheed